Hemocompatibility - GLP | Universitätsklinikum Tübingen

Hemocompatibility (GLP)

The research laboratory works within various publicly funded research projects on the improvement of the hemocompatibility of blood-contacting medical devices and also conducts application-oriented, industry-funded research projects. These investigations are performed, for example, for the comparative evaluation of new implant materials and/or coatings. Depending on the task, a suitable, individually selected hemocompatibility test from various tests available in the laboratory is used.

A certified quality assurance system based on the principles of "Good Laboratory Practice" (GLP) is established to perform these tests with the highest possible quality and reliability and to ensure the traceability of the results required by law. Compliance with the GLP principles is monitored by the Baden-Württemberg Ministry of Science.

A team of highly qualified specialists with several years of experience evaluates the hemocompatibility of blood-contacting medical devices according to DIN ISO EN 10993-4: Biological evaluation of medical devices - Part 4: Selection of blood tests for interactions.

Contact

frontend.sr-only_#{element.contextual_1.children.icon}: Prof. Dr. Meltem Avci-Adali Head of Department

frontend.sr-only_#{element.contextual_1.children.icon}: 07071 29-86605

frontend.sr-only_#{element.contextual_1.children.icon}: 07071 29-5369

External Scientific Consultant

frontend.sr-only_#{element.contextual_1.children.icon}: Prof. Dr. Hans Peter Wendel

Prof. Dr. Wendel has extensive experience in the field of hemostasis and activation of blood coagulation in response to artificial surfaces. He has several years of experience in the analysis and improvement of the hemocompatibility of medical devices. As an external scientific consultant, he supports our group with his excellent longstanding expertise and experience in the analysis of hemocompatibility and the GLP testing of diverse blood-contacting devices.

The goal of the non-clinical testing activity of the research laboratory is:

To provide blood-contacting medical device developers with decision support for product evaluations and to support them with comprehensive testing services

To support manufacturers of blood-contacting medical devices in the non-clinical evaluation of new products or new procedures
To enable national and international regulatory authorities to assess the conformity of medical devices

Through our non-clinical testing activities, research work, and translational application strategies, we aim to continuously improve medical devices and critically examine and evaluate also established and proven processes. The work of the clinical research laboratory aims to, directly and indirectly, improve patient care by developing and testing new materials and improving medical products to protect patients. Furthermore, using in-vitro methods, animal experiments can be prevented/reduced and the use of methods relevant to humans allows a more comparable evaluation of research results in humans. This is the mission of our work.